Enter assignee name

EPO Patents = 1

Forward Citations = 68

Loading Chart...

6 inventors (with patents filed for the assignee):

D Lorne Tyrrell (7 out of 18 patents)

Norman M Kneteman (7 out of 7 patents)

David Frederick Mercer (6 out of 6 patents)

4. John Elliott (1 out of 2 patents)

5. John B Sacci, Jr (1 out of 1 patent)

6. Abdu F Azad (1 out of 1 patent)

7. Lorne D Tyrrell (0 patent)

8. David F Mercer (0 patent)

7 patents: Sort by Forward Citations

1. 8445745 - Animal model having a chimeric human liver and susceptible to human hepatitis C virus infection (2013-05-21),

2. 8212106 - Animal model having a chimeric human liver and susceptible to human hepatitis C virus infection (2012-07-03),

3. 7781642 - Animal model having a chimeric human liver and susceptible to human hepatitis C virus infection (2010-08-24),

4. 7498479 - Animal model having a chimeric human liver (2009-03-03),

5. 7273963 - Malarial animal model having a chimeric human liver (2007-09-25),

6. 7161057 - Animal model having a chimeric human liver (2007-01-09),

7. 6509514 - Chimeric animal model susceptible to human hepatitis C virus infection (2003-01-21),

Kmt Hepatech, Inc. is a leading biotechnology company specializing in liver cell-based products and services for drug discovery and development. With a focus on advancing research in liver disease and related therapies, Kmt Hepatech offers innovative solutions to accelerate the drug development process. Their state-of-the-art hepatocyte-based platforms provide high-quality liver models for preclinical studies, enabling pharmaceutical companies to make informed decisions and streamline their drug discovery efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

7 Patents

#35 in Edmonton

#2,025 in Canada

Edmonton, Canada

Kmt Hepatech, Inc.